Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHARAD VIRMANI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1578795829
CMS profile
1275106
Location
LAWRENCEVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$12,899.50

81 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHARAD VIRMANI

NPI 1578795829 · CMS profile ID 1275106

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

LAWRENCEVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1578795829?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHARAD VIRMANI, NPI 1578795829, CMS profile ID 1275106. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578795829?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SHARAD VIRMANI, NPI 1578795829, CMS profile ID 1275106. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578795829?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SHARAD VIRMANI, NPI 1578795829, CMS profile ID 1275106, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1578795829?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

81 matching records · $12,899.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 81 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–81 of 81.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AKEBIA THERAPEUTICS INC $21.1207/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145826992 CMS
CALLIDITAS THERAPEUTICS US INC. $19.4007/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141517823 CMS
AstraZeneca Pharmaceuticals LP $75.3506/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105871671 CMS
Bayer Healthcare Pharmaceuticals Inc. $27.2806/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086233214 CMS
Amgen Inc. $22.2006/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116196124 CMS
Otsuka America Pharmaceutical, Inc. $27.7306/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119000385 CMS
Novo Nordisk Inc $8.9006/10/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097467047 CMS
Novartis Pharmaceuticals Corporation $15.0806/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087409900 CMS
Amgen Inc. $18.5405/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117710502 CMS
AstraZeneca Pharmaceuticals LP $23.3805/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104290080 CMS
AstraZeneca Pharmaceuticals LP $20.4505/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105544263 CMS
Fresenius USA Marketing, Inc. $25.8904/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154192933 CMS
CALLIDITAS THERAPEUTICS US INC. $28.0704/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141513317 CMS
Novartis Pharmaceuticals Corporation $15.6104/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087409898 CMS
AstraZeneca Pharmaceuticals LP $30.9504/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104743663 CMS
Amgen Inc. $15.3803/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116196121 CMS
Fresenius USA Marketing, Inc. $23.9803/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154192931 CMS
Amgen Inc. $4.6803/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116196116 CMS
AstraZeneca Pharmaceuticals LP $1,600.0003/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105563422 CMS
AstraZeneca Pharmaceuticals LP $23.2003/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104401207 CMS
AstraZeneca Pharmaceuticals LP $87.4403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104770650 CMS
Amgen Inc. $19.8202/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116196111 CMS
TheracosBio, LLC $5.8102/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146417559 CMS
CALLIDITAS THERAPEUTICS US INC. $21.8602/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141509987 CMS
Novartis Pharmaceuticals Corporation $17.0802/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087409892 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.6702/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118067185 CMS
AstraZeneca Pharmaceuticals LP $83.5302/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105612607 CMS
Aurinia Pharma U.S., Inc. $19.9802/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150694093 CMS
Otsuka America Pharmaceutical, Inc. $17.2401/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119000383 CMS
Travere Therapeutics, Inc. $22.7901/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149904292 CMS
Baxter Healthcare $13.3801/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120626517 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $732.15 28
PY2020 $261.80 15
PY2021 $668.52 41
PY2022 $776.86 45
PY2023 $20,134.71 65
PY2024 $12,899.50 81
PY2025 $19,805.77 82

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Recipient $1,091.59 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Gilead Sciences, Inc. $10.88 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480885
Recipient Gilead Sciences, Inc. $17.23 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480891
Recipient Gilead Sciences, Inc. $18.31 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480897
Recipient Gilead Sciences, Inc. $41.39 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480902
Recipient Gilead Sciences, Inc. $47.90 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480907
Recipient Gilead Sciences, Inc. $47.90 09/13/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480912
Recipient Gilead Sciences, Inc. $23.65 09/12/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480875
Recipient Gilead Sciences, Inc. $108.06 09/12/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480879
Recipient Gilead Sciences, Inc. $132.32 09/11/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480870
Recipient Gilead Sciences, Inc. $245.35 09/10/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480863
Recipient Gilead Sciences, Inc. $398.60 08/01/2019 Covered Recipient Physician A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease No dispute reported 06/30/2026 676480857